# Plasma cell leukemia with soft tissue involvement; reporting a rare case

**Authors:** Ahmed Bendari, Rahaf M. Abu Khalaf, Sunder Sham, Reham Al-Refai, Oana Vele, Alyssa Yurovitsky

PMC · DOI: 10.1016/j.lrr.2024.100411 · Leukemia Research Reports · 2024-01-09

## TL;DR

This paper reports a rare case of plasma cell leukemia involving soft tissue, highlighting its unusual clinical presentation and diagnostic features.

## Contribution

The novelty lies in documenting a rare instance of soft tissue involvement in plasma cell leukemia.

## Key findings

- A 74-year-old man presented with a plasma cell leukemia case involving soft tissue nodules.
- Diagnostic features included high leukocytosis, monoclonal IgG lambda band, and complex karyotype with monosomy 13 and 14q deletion.
- Bone marrow and biopsy findings confirmed plasma cell neoplasm with high Ki-67 proliferation index.

## Abstract

Plasma cell leukemia (PCL) is a rare aggressive variant of multiple myeloma. PCL is diagnosed when clonal plasma cells constitute more than 20 % of the total circulating leukocytes or when the absolute plasma cell count exceeds 2 × 109 /L. Extramedullary involvement including cavity effusion is frequently seen at the time of diagnosis. However, soft tissue involvement is rarely encountered with only one published case in the English literature. We report a 74-year-old man, who presented with progressive shortness of breath over a few months. Laboratory studies showed leukocytosis (32 × 109 /L) with 26 % peripheral plasmacytoid cells and significantly elevated lactate dehydrogenase (> 2500 U/L). Serum protein electrophoresis detected a monoclonal IgG lambda band. A 7.4 cm left hilar mass, bilateral pleural effusion, and multiple fluorodeoxyglucose (FDG)-avid subcutaneous nodules in the pelvic and gluteal regions were demonstrated on imaging. Gluteal nodule biopsy revealed diffuse infiltrative CD138+ and MUM1+ cells with aberrant CD4, CD30, and BCL2 expression. The Ki-67 proliferation index was 70 %. Bone marrow biopsy showed sheets of atypical plasma cells with lambda-restriction and CD138 and MUM1 expression without cyclin D1 and CD20 expression. These cells comprise approximately 70–80 % of the bone marrow cellularity. A similar immunophenotype was demonstrated in peripheral and bone marrow flow cytometry. Molecular and cytogenetics showed an abnormal clone with a complex karyotype including monosomy 13 and 14q deletion. Overall, these findings are consistent with a plasma cell neoplasm. Our case study illustrates soft tissue involvement in PCL, which is rarely seen.

## Linked entities

- **Proteins:** SDC1 (syndecan 1), IRF4 (interferon regulatory factor 4), CD4 (CD4 molecule), TNFRSF8 (TNF receptor superfamily member 8), BCL2 (BCL2 apoptosis regulator), ccnd1.S (cyclin D1 S homeolog), MS4A1 (membrane spanning 4-domains A1)
- **Diseases:** plasma cell leukemia (MONDO:0018689), multiple myeloma (MONDO:0009693)

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, PWWP3A (PWWP domain containing 3A, DNA repair factor) [NCBI Gene 84939] {aka EXPAND1, HSPC211, MUM-1, MUM1}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, TNFRSF8 (TNF receptor superfamily member 8) [NCBI Gene 943] {aka CD30, D1S166E, Ki-1}, CD58 (CD58 molecule) [NCBI Gene 965] {aka LFA-3, LFA3, ag3}, HLA-G (major histocompatibility complex, class I, G) [NCBI Gene 3135] {aka MHC-G}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, CD2 (CD2 molecule) [NCBI Gene 914] {aka LFA-2, SRBC, T11}, ITGB2 (integrin subunit beta 2) [NCBI Gene 3689] {aka CD18, LAD, LCAMB, LFA-1, MAC-1, MF17}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, DIS3 (DIS3 exosome endoribonuclease and 3'-5' exoribonuclease) [NCBI Gene 22894] {aka 2810028N01Rik, EXOSC11, KIAA1008, RRP44, dis3p}, CKS1B (CDC28 protein kinase regulatory subunit 1B) [NCBI Gene 1163] {aka CKS1, PNAS-16, PNAS-18, ckshs1}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}
- **Diseases:** MM (MESH:D009101), monosomy 13 (MESH:D018344), toxicities (MESH:D064420), Plasma Cell Leukemia (MESH:D007952), bone disease (MESH:D001847), anemia (MESH:D000740), renal dysfunction (MESH:D007674), leukocytosis (MESH:D007964), hypercalcemia (MESH:D006934), plasma cell neoplasm (MESH:D054219), extramedullary involvement (MESH:D023981), shortness of breath (MESH:D004417), cytopenia (MESH:D006402), neoplastic (MESH:D009369), M (MESH:C566367), cavity effusion (MESH:D000080324), lymphadenopathy (MESH:D008206), pleural effusion (MESH:D010996), hilar mass (MESH:C536030), renal insufficiency (MESH:D051437), leukemic (MESH:D007938)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10821604/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10821604/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC10821604/full.md

---
Source: https://tomesphere.com/paper/PMC10821604